Systemic anti-CTLA-4 and intravesical Bacille-Calmette-Guerin therapy in non-muscle invasive bladder cancer: is there a rationale of synergism?

Fahmy, Omar; Khairul-Asri, Mohd Ghani; Stenzl, Arnulf; Gakis, Georgios

dc.contributor.author	Fahmy, Omar
dc.contributor.author	Stenzl, Arnulf
dc.contributor.author	Gakis, Georgios
dc.date.accessioned	2016-11-08T11:13:21Z
dc.date.available	2016-11-08T11:13:21Z
dc.date.issued	2016
dc.identifier.issn	1532-2777
dc.identifier.uri	http://hdl.handle.net/10900/73099
dc.language.iso	en	de_DE
dc.publisher	Churchill Livingstone	de_DE
dc.relation.uri	http://dx.doi.org/10.1016/j.mehy.2016.04.037	de_DE
dc.rights	info:eu-repo/semantics/closedAccess
dc.subject.ddc	610	de_DE
dc.title	Systemic anti-CTLA-4 and intravesical Bacille-Calmette-Guerin therapy in non-muscle invasive bladder cancer: is there a rationale of synergism?	de_DE
dc.type	Article	de_DE
utue.quellen.id	20160915142648_00311
utue.publikation.seiten	57-58	de_DE
utue.personen.roh	Fahmy, Omar
utue.personen.roh	Khairul-Asri, Mohd Ghani
utue.personen.roh	Stenzl, Arnulf
utue.personen.roh	Gakis, Georgios
dcterms.isPartOf.ZSTitelID	Medical Hypotheses	de_DE
dcterms.isPartOf.ZS-Volume	92	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE